Connor, Clark & Lunn Investment Management (CC&L)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-13,207
Closed -$966K 1215
2020
Q2
$966K Buy
+13,207
New +$966K 0.01% 624